[[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D004977:Ethambutol / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000009:adverse effects; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011859:Radiography; D013307:Streptomycin / Q000008:administration & dosage* / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D000636:Aminosalicylic Acids; D004977:Ethambutol; D007538:Isoniazid; D013307:Streptomycin